دورية أكاديمية

Too young to fail: a case report on the effectiveness of tocilizumab for paediatric systemic sclerosis-associated interstitial lung disease.

التفاصيل البيبلوغرافية
العنوان: Too young to fail: a case report on the effectiveness of tocilizumab for paediatric systemic sclerosis-associated interstitial lung disease.
المؤلفون: Maniscalco, V, Marrani, E, Rossi, E, Maccora, I, Mastrolia, MV, Simonini, G
المصدر: Scandinavian Journal of Rheumatology; Nov 2021, Vol. 50 Issue 6, p491-492, 2p
مصطلحات موضوعية: INTERSTITIAL lung diseases, PEDIATRICS, TOCILIZUMAB, SYSTEMIC scleroderma, RAYNAUD'S disease, DIAGNOSIS
مستخلص: The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab. Response to: 'Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series' by Narváez. [Extracted from the article]
Copyright of Scandinavian Journal of Rheumatology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03009742
DOI:10.1080/03009742.2021.1881154